|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910253860903321 |
|
|
Titolo |
Clinical Pharmacology: Current Topics and Case Studies / / edited by Markus Müller |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[2nd ed. 2016.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (398 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Pharmacology |
Pharmacy |
Pharmacotherapy |
Pharmacology/Toxicology |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
The discipline of Clinical Pharmacology -- Current issues in drug development -- Current issues in drug regulation -- Current issues in drug reimbursement -- Ethics of clinical research -- GCP, Scientific misconduct -- Phases of drug development, first in man studies -- Clinical trials - Interventional studies -- Clinical trials - observational studies -- Imaging -- Microdosing -- Genomics -- Pharmacokinetics/Pharmacodynamics -- Epidemiology, statistics -- Placebo effects -- Pharmaceutical drug safety -- Drug interactions -- Advanced therapies -- Biological pharmaceuticals -- Generic drugs, Enantiomers -- Special situations I: orphan drugs -- Special situations II: sex differences -- Special situations III: children. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This revised and extended second edition focuses on current and emerging topics in drug development, their molecular mechanisms of action as well as regulatory issues. In addition, in-depth insights into clinical drug research and trial methodology are presented on the basis of concrete case studies. This updated book makes a valuable contribution to the field of Clinical Pharmacology and serves as a must-have guide for professors, researchers and advanced students from academia and pharmaceutical industry. . |
|
|
|
|
|
|
|